Modulation Of Impaired Cholinesterase Activity In Experimental Diabetes: Effect Of Gymnema Montanum Leaf Extract

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 16, Issue 1, 2005, Pages 17-36

  Ramkumar, Kunga Mohan ^a   Latha, Muniappan ^a   Ashokkumar, Natarajan ^a   Pari, Leelavinothan ^a   Ananthan, Rajendran ^b  

^a ANNAMALAI UNIVERSITY   (India)

^b BHARATHIAR UNIVERSITY   (India)

Author keywords

AChE; BChE; lipid peroxidation; streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; GLUCOSE; GYMNEMA MONTANUM EXTRACT; INSULIN; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDANGERED SPECIES; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GYMNEMA MONTANUM; HYPERGLYCEMIA; INDIA; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; RAT; STREPTOZOCIN DIABETES;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD GLUCOSE; BRAIN; BUTYRYLCHOLINESTERASE; CHOLINESTERASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GYMNEMA; INSULIN; LIPID PEROXIDATION; MALE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; RETINA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 24944579576     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2005.16.1.17     Document Type: Article

References (65)

1. Greeg, E.W., Brown, A. Cognitive and physical disabilities and aging related complications of Diabetes. Clin Diabetes 2003; 21:113–118.
2. Biessels, G.J., Kappelle, A.C., Bravenboer, B., Erkelens, D.W., Gispen, W.H. Cerebral function in diabetes mellitus. Diabetologia 1994; 37: 643–650.
3. Lingenfelser, T., Overkamp, D., Renn, W., Buettner, U., Kimmerle, K., Schmalfuss, A., Jakober, B. Insulin-associated modulation of neuroendocrine counterregulation, hypoglycemia perception, and cerebral function in insulin-dependent diabetes mellitus: evidence for an intrinsic effect of insulin on the central nervous system. J Clin Endocrinol Metab 1996; 81: 1197–1205.
4. Goodman, J.I. The specific vascular lesions of diabetes mellitus. II. Retinopathy and intercapillary glomerulosclerosis. Am J Ophthalmol 1953; 36:957–966.
5. Wohaieb, S.A., Godin, D.V. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36: 1014–1018.
6. Maxwell, S.R., Thomason, H., Sandler, D., Leguen, C., Baxter, M.A., Thorpe, G.H., et al. Antioxidant status in patients with uncomplicated insulindependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27:484–490.
7. Pereira, B., Rosa, L.F., Safi, D.A., Bechara, E.J., Curi, R. Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs of diabetic rats. J Endocrinol 1994; 142: 161–165.
8. Griesmacher, A., Kindhauser, M., Andert, S.E., Schreiner, W., Toma, C., Knoebl, P., et al. Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469–485.
9. Chatonnet, A., Lockridge, O. Comparison of acetyl and butyryl cholinesterases. Biochem J 1989; 260: 625–634.
10. Dash, N.K., Azam, M., Gupta, G., Baquer, N.Z. Effect of hyperglycemia on acetylcholinesterases and catecholamine levels in rat brain and heart. Biochem Int 1991; 23: 261–269.
11. Khandkar, M.A., Mukherjee, E., Parnar, S.D.P., Katyare, S.S. Alloxan diabetes alters kinetic properties of the membrane bounds form but not of the soluble form of acetylcholinesterase in rat brain. Biochem Journal 1995; 307: 647–649.
12. Suhail, M., Rizvi, S.I. Erythrocyte membrane acetylcholinesterase in type 1 (insulin-dependent) diabetes mellitus. Biochem J 1989; 259: 897–899.
13. Sanchez-Chavez, G., Salceda, R. Acetyl and Butyrylcholinesterase in normal and diabetic rat retina. Neurochem Res 2001; 26: 153–159.
14. Olney, J.W., Collins, R.C., Sloviter, R.S. Eciotoxic mechanisms of epileptic brain damage. Adv Neurol 1986; 44: 857–877.
15. Rakonczay, Z., Vincendon, G., Zanetta, J.P. Heterogenicity of rat brain acetylcholinesterase: A study by gel filtration and gradient centrifugation. J Neurochem 1981; 37: 662–669.
16. Rakonczay, Z. Mammalian brain acetylcholinesterase In: Boulton AA, Baker GB, Yu PH, eds, Neuromethods vol 5. New York, N., USA: 1986; 319–360.
17. Ragoobirsingh, D., Bhraj, B.S., Morrison, E.Y. Changes in serum cholinesterases activity in Jamaican diabetes. J Natl Med Assoc 1992; 84: 853–855.
18. Floyd, R.A., Zaleska, M.M., Harmon, J. Free radicals in molecular biology, ageing and disease. In: Armstrong D, Sohal RS, Cutler RG, Slater TF, eds, Ageing. New York, N., USA: Raven Press, 1984; 143–161
19. Low, P.A., Nickader, K.K., Tritschler, H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46: S38–S42.
20. Hammes, H.P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., Deutsch, U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002; 51:3107–3112.
21. Obrosova, I.G., Minchenko, A.G., Marinescu, V., Fathallah, L., Kennedy, A., Stockert, C.M., Frank, R.N., Stevens, M.J. Antioxidants attenuate early upregulation of retinal vascular endothelial growth factor in streptozotocin diabetic rats. Diabetologia 2001; 44: 1102–1110.
22. Hammes, H.P., Brownlee, M., Lin, J., Schleicher, E., Bretzel, R.G. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Ne-(carboxymethyl)lysine independently of glycohaemoglobin concentrations. Diabetologia 1999; 42: 603–607.
23. Kow luru, R.A., Kern, T.S., Engerman, R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1997; 22: 587–592.
24. World Health Organization. Expert Committee on Diabetes mellitus. Second Report-Technical Report Service 646. Geneva, Switzerland: WHO, 1980.
25. Grover, J.K., Yadav, S., Vats, V. Medicinal plants of India with antidiabetic potential. J Ethnopharmacol 2002; 81: 81–100.
26. Hooker, J.D. Asclepiadaceae. Hookers flora of British India. 1883; 4:31.
27. Vajravelu, E., Bhargavan, P. Rare and endemic species re-collected after fifty years or more from South India. An assessment of threatened plants of India. Proceedings of the seminar Dehradun. Jain SK, Raw RR, eds, Howrah: BSI, Botanic garden 1983; 14–17.
28. Subbarayalu, S., Velmurugan, S. Gymnema montanum Hook. In: Subbarayalu S, Velmurugan S, eds, Endangered Plant Species in Tamil Nadu. Bharathi computers and offset 1999; 103.
29. Sanchez-Chavez, G., Salceda, R. Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 2000; 49:283–287.
30. Ananthan, R., Latha, M., Pari, L., Ramkumar, K.M., Baskar, C., Narmatha Bai, V. Effect of Gymnema montanum on blood glucose, plasma insulin and carbohydrate metabolic enzymes in alloxan induced diabetic rats. J Med Food 2003; 6:43–49.
31. Ananthan, R., Latha, M., Ramkumar, K.M., Pari, L., Baskar, C., Narmatha Bai, V. Effect of Gymnema montanum leaves on serum and tissue lipids in alloxan diabetic rats. Exp Diab Res 2003; 4: 183–189
32. Ananthan, R., Baskar, C., Narmatha Bai, V., Pari, L., Latha, M., Ramkumar, K.M. Antidiabetic effect of Gymnema montanum leaves: Effect on lipid peroxidation induced oxidative stress in experimental diabetes. Pharmocol Res 2003; 48: 551–556.
33. Ananthan, R., Latha, M., Ramkumar, K.M., Pari, L., Baskar, C., Narmatha Bai, V. Modulatory effects of Gymnema montanum leaf extract on alloxan-induced oxidative stress in Wistar rats. Nutrition 2004; 20: 280–285.
34. Ramkumar, K.M., Latha, M., Pari, L., Ananthan, R., Baskar, C., Narmatha Bai, V. Modulatory effect of Gymnema montanum leaf extract on brain antioxidant status and lipid, peroxidation in diabetic rats. J Med Food 2004; 7: 366–371.
35. Hossain, M.Z., Shibib, B.A., Rahman, R. Hypoglycemic effects of Coccinia indica: Inhibition of key gluconeogenic enzyme, glucose-6-phosphatase. Ind J Exp Biol 1992; 10: 418–420.
36. Bonner Weir, S., Trent, D.F., Honey, R.N., Weir, G.C. Response of neonatal rat islets to streptozotocin. Limited ß-cell regeneration and hyperglycemia. Diabetes 1981; 30: 64–69.
37. Sberna, G., Saez-Valero, J., Li, Q.X., Czech, C., Beyreuther, K., Masters, C.L., et al. Acetylcholinesterase is increased in the brains of transgenic mice exposing the C-Terminal Fragment (CT 100) of the ß-Amyloid protein precursor of Alzheimer's disease. J Neurochem 1998; 71: 723–731.
38. Sanchez-Chavez, G., Salceda, R. Acetyl and butyrylcholinesterase molecular forms in normal and streptozotocin diabetic rat retinal pigment epithelium. Neurochem Int 2001 b; 39: 209–215.
39. Sasaki, T., Matsy, S., Sonae, A. Effect of acetic acid concentration on the colour reaction in the 0-toluidine boric acid method for blood glucose estimation. Rinshbo Kagaku 1972; 1: 346–353. START
40. Nichans, W.G. Jr, Samuelsson, B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968; 6: 126–130
41. Ellman, G.L., Courtney, K.D., Andres, V.J., Featherstone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Anal Biochem 1961; 64: 136–141.
42. Duncan, B.D. Multiple range test for correlated and heteroscedastic means. Biometrics 1957; 13: 359–364.
43. Aragno, M., Parola, S., Tamagno, E., Brignardello, E., Manti, R., Danni, O. Boccuzzi, G. Oxidative derangement in rat synaptosomes induced by hyperglycemia: restorative effect of dehydroepiandrosterone treatment. Biochem Pharmacol 2000; 3: 389–395.
44. Kawai, N., Keep, R.P., Betz, A.L., Nagao, S. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. Acta Neurochem 1998; 71: 219–221.
45. Kumar, J.S., Menon, V.P. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993; 42: 1435–1439.
46. Bellush, L.L., Reid, S.G. Altered behavior and neurochemistry during short-term insulin withdrawal in streptozotocin induced diabetic rats. Diabetes 1991;40:217–222.
47. Nistico, G., Cirilol, H.R., Fiskin, K., lannone, M., Martino, A., Rotilio, G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad Biol Med 1992; 12: 177–181.
48. Walling, C. Fenton's reagent revisited. J Am Chem Soc 1975; 8: 125–129.
49. Lubec, B., Hayn, M., Denk, W., Bauer, G. Brain lipidperoxidation and hydroxyl radical attack following the intravenous infusion of hydrogen peroxide in an infant. Free Rad Biol Med 1996; 21: 219–223.
50. Massoulie, J., Pezzementi, L., Bon, S., Krejci, E., Vallete, F.M. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993; 41: 31–91.
51. Reyes, A.E., Perez, S.D.R., Alvarez, A., Garrido, J., Gentry, M.K., Doctor, B.P., Inestrosa, N.C. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem Biophy Res Comm 1997; 232: 652–655.
52. Rizvi, S.I., Zaid, M.A. Insulin like effect of (-) epicatechein on erythrocyte membrane acetyl cholinesterases in type 2 diabetes mellitus. Clin Exp Pharmacol Physiol 2001; 28: 776–778.
53. Rinne, J.O., Kaasinen, V., Jarvenpaa, T., Nagren, K., Roivainen, A., Yu, M., Oikonen, V., Kurki, T. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's diseases. J Neurol Psychol 3;74: 113–115.
54. Fishman, E.B., Siek, G.C., MacCallun, R.S.D., Bird, E.D.S., Volicer, L., Marquis, J.K., Distribution of the molecular forms of acetylcholinesterase in human brain. Alterations in dementia of the Alzheimer type. Annal Neur 1986; 19: 246–253.
55. Ruberg, M., Rieger, F., Villageois, A., Bonnet, A.M., Agid, Y. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluids in demented and non-demented patients with Parkinson's disease. Brain Res 1986; 362: 83–91.
56. Mesulam, M.M., Geula, C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 1994; 36:722–727.
57. Saez-Valero, J., Visdal, C.J. Biochemical properties of acetyl and butyrylcholinesterase in human meningioma. Biochim Biophy Acta 1996; 1317:210–218.
58. Layer, P.G., Willbold, E. Novel functions of Cholinesterases in development, physiology and disease. Prog Histochem Biochem 1995; 29:1–94.
59. Walsdbilling, R.J., Fletcher, R.T., Chader, A.J., Rajagopalan, S., Rodrigues, M., LeRoith, S.D. Retinal insulin receptors. Characterization and insulin tyrosine kinase activity in bovine retinal rod outer segments. Exp Eye Res 1987; 45: 837–844.
60. Murakami, N., Murakami, T., Kadoya, M., Matsuda, H., Yamahara, J., Yoshikawa, M. New hypoglycaemic constituents in ‘gymnemic acid’ from Gymnema sylvestere. Chem Pharm Bull 1996; 44: 469–471.
61. Persaud, S.J., Al-Majed, H., Raman, A., Jones, P.M. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol. 1999; 163:207–212.
62. Dateo, G.P. Jr. Long, L. Jr. Gymnemic acid, the antisaccharine principle of Gymnema sylvestre. Studies on the isolation and heterogeneity of gymnemic acid A1. J Agric Food Chem. 1993 Sep-Oct; 21(5):899–903.
63. Sugihara, Y., Najima, H., Matsuda, H., Murakami, T., Yoshikawa, M., Kimura, I. Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozo-tocin-diabetic mice. J Asian Nat Prod Res 2000; 2: 321–327.
64. Venkateswaran, S., Pari, L. Antioxidant effect of Phaseolus vulgaris in streptozotocin-induced diabetic rats. Asia Pac J Clin Nut 2002; 11:206–209.
65. Latha, M., Pari, L., Sitasawad, S., Bhonde, R. Insulin-secretagogue activity and cytoprotective role of the traditional antidiabetic plant Scoparia dulcis (Sweet Broomweed). Life Sciences 2004; 75: 2003–2014.